Skin necrosis, arising from abnormality in the anticoagulant arm of the coagulation cascade, is increasingly recognized in the anti phospholipidantibody syndrome, coumarin necrosis and protein C deficiency'P. Protein S deficiencyin association with coumarin therapy has recently received similar attention", We report a case of skin necrosis associated with protein S deficiencyand lupus anticoagulant. This combination may lead to cutaneous infarction without coumarin.
Case report
A 67-year-old woman underwent left above knee and right below knee amputations, in 1980 and 1982 respectively, for persistent leg pain at rest. She was a nonsmoker with no known risk factors for arterial disease. Subsequently she remained well on no medication.
In October 1988 she presented with a 3-month history of spontaneous non-healing ulceration of her distal right stump. When conservative management failed, she was admitted for surgical debridement and revision of the right stump. Heparin 5000 iu subcutaneously three times a day was given perioperatively. Three days later she developed reticulate areas of cutaneous necrosis on both thighs with firm subcutaneous swellings and, in places, frank eschar formation <Figure 1).
Laboratory investigations, off all anticoagulants, demonstrated a lupus anticoagulant plus protein C and S deficiencies. Serial coagulation studies are summarized in Table 1 . Skin biopsies from affected areas showed intravascular thrombus in dermal and subcutaneous vessels with associated areas of full thickness infarction. There was Table 1 . Serial coagulation studies Figure 1 . Cutaneous infarction on right thigh no vasculitis in any section.Erythrocyte sedimentation rate was elevated at 120 mm/h but all other investigations pertaining to vasculitis or thrombotic states were normal or negative.
She was stabilized on warfarin under heparin cover. Despite initial improvement, further areas of cutaneous necrosis developedon both thighs. Coagulation studies, repeated while on warfarin, found an international normalized ratio (lNR) of 2.1, vitamin K-dependent procoagulant factors II, VII, IX and X all mildly reduced consistent with anticoagulation, protein C 57 iuJdl (normal >65 iuJdl)and free protein S 25% pooled normal plasma (normal range > 65%).
Her warfarin doses were increased to stabilize the INR between 2.5 and 3.5. Thereafter, all cutaneous lesions steadily resolved and have remained healed some 8 months later. Subsequent coagulation studies ( 
Discussion
The protein C system is an anticoagulant arm of the coagulation cascade. Protein S is a cofactor for activated protein C and both are vitamin K-dependent proteins. Activated protein C inactivates coagulation factors Va and Villa by cleaving them", Thrombomodulin, a high affinity thrombin receptor found on vascular endothelial walls, greatly enhances activation of protein C by thrombin". This enhancement is potentiated by the presence of phospholipids". Protein S complexes with activated protein C on phospholipid vesicles and causes a 10-fold increase in protein C's inactivation of factor Va 6 • Familial protein S deficiency has an autosomal dominant inheritance". Heterozygotes develop recurrent thrombotic events, particularly venous thrombosis and superficial thrombophlebitis" but also coumarin necrosis" and arterial disease Despite a similar prevalence", protein S deficiency is much less frequently described than protein C deficiency. This is partly because no satisfactory functional assay is routinely available for protein S. In addition, 60% of circulating protein S is normally bound to the complement component C4b-binding protein and only the 'free' fraction appears to be active!", Consequently, increased binding to C4b-binding protein will result in a deficiency state despite normal amounts of total protein S.
Acquired protein C and S deficiencies are seen in consumptive coagulopathies such as disseminated intravascular coagulation" or meningococcal-associated purpura fulminans". Levels measured acutely following a thrombotic event must be interpreted with caution. Therapeutic anticoagulation further complicates the picture. Comparison with other vitamin K-dependent proteins is helpful'? and confirmation of an inherited deficiency should be sought from family studies. This was not possible with our patient who has no living relatives. Nonetheless, she appears to have a genuine protein S deficiency with consistently reduced free protein S levels of around 25%. The initial very low protein C level probably reflects an 'acute phase' consumption and subsequent levels of around 50 iuldl are consistent with warfarin anticoagulation.
It is interesting to speculate on the significance of the persistent lupus anticoagulant. Lupus anticoagulant can interfere with protein C activation':". Since protein S complexes with activated protein C on phospholipid vesicles", it seems possible that this antiphospholipid antibody may similarly produce a functional protein S deficiency. Alternatively, one could postulate a reduction in free protein S through an associated increase in C4b-binding protein. A recent report" lends credence to the latter.
Reported associations of protein S deficiency with arterial disease IO -12 provide a possible explanation for this patient's unusually severe arteriopathy which led to bilateral leg amputations in a nonsmoker.
Skin necrosis in the absence of coumarin has not previously been described in protein S deficiency. This patient had received no warfarin prior to skin necrosis developing so, despite the striking clinical resemblance to classical coumarin necrosis, this aetiological factor cannot be Journal of the Royal Society of Medicine Volume 83 October 1990 647 implicated. Indeed, this combination of free protein S deficiency and lupus anticoagulant was sufficiently thrombogenic for the cutaneous necrosis to develop despite prophylactic heparinization.
